News Information
Focusing on cutting-edge technology and conveying industry voices
Applications and Future Trends of Cell-Free Protein Expression Technology
Release date:
2026-06-10
Cell-Free Protein Synthesis (CFPS) has grown rapidly in the fields of synthetic and structural biology in recent years. It is steadily evolving from a basic laboratory tool into a vital technology platform for protein engineering and drug discovery. The core of this technology lies in the in vitro reconstitution of transcription and translation systems, enabling the rapid synthesis of target proteins while completely bypassing the complex regulatory networks found inside living cells.
Figure 1 | Schematic diagram of the Cell-Free Protein Synthesis (CFPS) system (Reference [3])
Traditional cell-based expression systems (such as E. coli, insect cells, and mammalian cells) each offer unique advantages for protein expression. However, they still hit significant bottlenecks when it comes to producing membrane proteins or complex proteins. These hurdles include expression toxicity, misfolding, and the lack of a native membrane environment. In contrast, the open environment of the CFPS system allows researchers to directly tweak reaction components, offering a much higher degree of freedom when optimizing expression conditions.
This flexibility is a game-changer for membrane protein research. Membrane proteins usually contain multiple hydrophobic transmembrane domains, making them highly prone to inactivation or misfolding in traditional cell-based systems. In a CFPS system, however, detergents or nanodiscs can be added directly to simulate a native membrane environment, which helps the proteins fold correctly and retain their function.
Figure 2 | Schematic diagram of a Nanodisc simulating a membrane environment (Reference [4])
For example, in the study of G protein-coupled receptors (GPCRs), pairing CFPS with nanodisc systems has been shown to significantly boost protein stability and functional retention. This provides high-quality samples essential for ligand-binding assays and structural analysis. Similarly, when studying ion channel proteins, tweaking the lipid makeup can effectively improve membrane insertion efficiency and structural stability.
With the boom in Cryo-electron microscopy (Cryo-EM) technology, structural biology’s demand for premium protein samples has skyrocketed. By teaming up with nanodisc systems, CFPS can deliver highly uniform protein samples, dramatically cutting down the time needed for structural screening.
Beyond structural biology, CFPS is seeing widespread use in protein engineering and high-throughput screening. Because it doesn't rely on cell growth, researchers can run micro-reaction systems in parallel. This is incredibly useful for screening protein mutant libraries, conducting directed evolution, and verifying functions—drastically accelerating the Design-Build-Test-Learn (DBTL) cycle.
In the drug discovery space, CFPS shows massive potential. Whether it’s prepping target proteins, screening antibodies, or running small molecule binding assays, CFPS can quickly churn out functional proteins to speed up the early-stage drug screening pipeline. It is especially well-suited for membrane protein targets.
Despite its rapid advancement, CFPS technology still faces a few hurdles, such as the folding efficiency of highly complex proteins, the expression stability of long-chain proteins, and the overall cost of the system. As a result, current research is heavily focused on optimizing energy systems, introducing molecular chaperones, and upgrading membrane simulation systems.
As this technology evolves, the engineering and integration centered around CFPS systems is becoming a major industry trend. Suzhou Protein Biotechnology Co., Ltd., for instance, has leveraged cell-free protein expression to meet the specific needs of membrane protein research. They are continuously fine-tuning their detergent-optimized systems and nanodisc reconstitution tech to offer more stable, controllable experimental solutions for membrane protein expression and structural studies. This shift from a standalone expression technique to a comprehensive, systematic platform highlights how CFPS is transitioning into a foundational "infrastructure for protein research."
About Suzhou PLD Technology Co., Ltd.
Suzhou PLD Technology Co., Ltd. specializes in cell-free protein synthesis technology, dedicated to accelerating the development of novel biopharmaceuticals, personalized medicines, and advanced diagnostic tools through this pioneering platform. Leveraging its expertise, Suzhou PLD Technology enables the swift and efficient production of intricate proteins in a controlled setting, precisely tailored to meet specific therapeutic and diagnostic requirements. Our sophisticated facilities and groundbreaking technologies form a solid basis for conducting high-quality research and guaranteeing the reliability and safety of our products. The company offers a comprehensive suite of cell-free protein expression tools, protein reagents, and customized services tailored to biomedical enterprises and research institutions.
The Bottom Line: Cell-Free Protein Synthesis is moving beyond its roots as a traditional protein prep tool and establishing itself as a crucial technology platform driving structural biology and drug discovery. As systems are optimized and multiple technologies merge, its potential in membrane protein research and the broader biopharmaceutical industry will only continue to grow.
References
- [1] Shimizu Y, et al. Cell-free translation reconstituted with purified components. Nature Biotechnology, 2001.
- [2] Katzen F, Chang G, Kudlicki W. The past, present and future of cell-free protein synthesis. Trends in Biotechnology, 2005.
- [3] Silverman AD, Karim AS, Jewett MC. Cell-free gene expression: an expanded repertoire of applications. Nature Reviews Genetics, 2020.
- [4] Ritchie TK, et al. Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods in Enzymology, 2009.
- [5] Dörr JM, et al. The styrene–maleic acid copolymer: a versatile tool in membrane research. BBA, 2016.
Learn more at: www.cellfreeprotein.cn
Latest News
Contact Information
Service Hotline: +86-512-67900128
Customer Service: order@sz-pld.tech
Business Cooperation: bd@sz-pld.tech
Address: Room 302, Building 1, Weili Medical Science and Technology Park, No. 69 Jiepu Road, Suzhou Industrial Park
